Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Total Liabilities (2018 - 2025)

Historic Total Liabilities for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $40.9 million.

  • Dna X's Total Liabilities rose 2107.23% to $40.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $40.9 million, marking a year-over-year increase of 2107.23%. This contributed to the annual value of $45.4 million for FY2024, which is 3493.39% up from last year.
  • As of Q3 2025, Dna X's Total Liabilities stood at $40.9 million, which was up 2107.23% from $37.4 million recorded in Q2 2025.
  • Dna X's 5-year Total Liabilities high stood at $45.4 million for Q4 2024, and its period low was $21.3 million during Q1 2021.
  • Moreover, its 5-year median value for Total Liabilities was $31.1 million (2023), whereas its average is $31.2 million.
  • As far as peak fluctuations go, Dna X's Total Liabilities crashed by 2898.55% in 2021, and later surged by 6427.3% in 2025.
  • Over the past 5 years, Dna X's Total Liabilities (Quarter) stood at $22.5 million in 2021, then skyrocketed by 49.78% to $33.6 million in 2022, then grew by 0.1% to $33.7 million in 2023, then soared by 34.93% to $45.4 million in 2024, then dropped by 9.95% to $40.9 million in 2025.
  • Its Total Liabilities was $40.9 million in Q3 2025, compared to $37.4 million in Q2 2025 and $37.0 million in Q1 2025.